George Lowell
Founder chez Healables Digital Health
Fortune : 548 $ au 31/03/2024
Profil
George H.
Lowell was the founder of Intellivax International, Inc. founded in 1995 where he held the title of President & Chief Scientific Officer until 2001.
Dr. Lowell is also the founder of Healables Digital Health, Inc. Dr. Lowell's former jobs include being an Independent Director at Scinai Immunotherapeutics Ltd.
from 2013 to 2023, Director-Laboratories at Walter Reed Army Institute of Research, Chief Scientific Officer at ID Biomedical Corp.
from 2001 to 2006, and Chief Scientific Officer-BioDefense at GlaxoSmithKline Biologicals NV from 2006 to 2007.
Dr. Lowell's education history includes an undergraduate degree from Yeshiva University and a doctorate from Albert Einstein College of Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2023 | 421 600 ( 0,06% ) | 548 $ | 31/03/2024 |
Postes actifs de George Lowell
| Sociétés | Poste | Début |
|---|---|---|
Healables Digital Health
 Healables Digital Health Electronic Equipment/InstrumentsElectronic Technology Healables Digital Health, Inc. develops wearable and therapeutic smart textiles. The company is based in Miami, FL. The company was founded by Moshe Lebowitz, George H. Lowell. Moshe Lebowitz has been the CEO since incorporation. | Founder | - |
Anciens postes connus de George Lowell
| Sociétés | Poste | Fin |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Director/Board Member | 12/05/2023 |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Chief Tech/Sci/R&D Officer | 01/01/2007 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2006 |
Intellivax International, Inc.
 Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The private company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Founder | 01/01/2001 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | - |
Formation de George Lowell
| Yeshiva University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Intellivax International, Inc.
Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The private company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Health Technology |
| Walter Reed Army Institute of Research | |
Healables Digital Health
Healables Digital Health Electronic Equipment/InstrumentsElectronic Technology Healables Digital Health, Inc. develops wearable and therapeutic smart textiles. The company is based in Miami, FL. The company was founded by Moshe Lebowitz, George H. Lowell. Moshe Lebowitz has been the CEO since incorporation. | Electronic Technology |
